v3.26.1
Stock-Based Compensation (Tables)
 3 Months Ended
Mar. 31, 2026
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock Option Activity
The following table summarizes the activities for all stock options under the Company’s stock-based compensation plans for the three months ended March 31, 2026:
Number of Options OutstandingWeighted-Average Exercise PriceWeighted-Average Remaining Contractual TermAggregate Intrinsic Value(1)
Outstanding as of December 31, 2025(2)7,958 $13.08 3.20 years$424 
Granted— $— 
Exercised(10)$2.68 
Forfeited or expired(3)(35)$5.90 
Outstanding as of March 31, 2026(2)7,913 $13.12 2.95 years$— 
Exercisable as of March 31, 2026(4)7,887 $13.15 2.93 years$— 
Vested and expected to vest as of March 31, 2026(5)7,913 $13.12 2.95 years$— 
(1)The intrinsic value is the amount by which the current market value of the underlying stock exceeds the exercise price of the stock awards.
(2)Includes 3,528 and 3,530 performance condition stock options as of March 31, 2026 and December 31, 2025, respectively.
(3)Includes 2 performance condition stock options.
(4)Includes 3,528 performance condition stock options.
(5)Includes 3,528 performance condition stock options.
Schedule of Restricted Stock Unit Activity
The following table summarizes the activities for all RSUs under the Company’s stock-based compensation plans for the three months ended March 31, 2026:
Number of SharesWeighted-Average Grant Date Fair Value Per Share
Outstanding as of December 31, 2025(1)2,316 $3.69 
Granted(2)1,302 $3.36 
Vested(378)$4.96 
Forfeited(3)(230)$3.36 
Outstanding as of March 31, 2026(1)3,010 $3.42 
(1)Includes 742 and 323 performance condition RSUs as of March 31, 2026 and December 31, 2025, respectively.
(2)Includes 580 performance condition RSUs.
(3)Includes 161 performance condition RSUs.
Schedule of Stock-Based Compensation Expense
The following table provides information about stock-based compensation expense by award type:
Three Months Ended
March 31,
2026		March 31,
2025
Stock options$— $334 
Restricted stock units789 1,026 
Employee stock purchase plan402 383 
Total stock-based compensation expense$1,191 $1,743 
The following table provides information about stock-based compensation expense by financial statement line item:
Three Months Ended
March 31,
2026		March 31,
2025
Cost of revenue (exclusive of depreciation and amortization)$— $— 
Sales and marketing217 264 
Research and development255 318 
General and administrative719 1,161 
Total stock-based compensation expense$1,191 $1,743